| RS398124347 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS398124348 |
ALG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Congenital disorder of glycosylation |
| RS398124349 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS398124350 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS398124351 |
MCCC1
|
Health Risk |
Likely pathogenic |
— |
| RS398124352 |
MCCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 1 deficiency, MCCC1-related disorder |
| RS398124353 |
MCCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124354 |
RPGRIP1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis 6 |
| RS398124355 |
RPGRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 6, Cone-rod dystrophy 13 |
| RS398124356 |
RPGRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 13, Leber congenital amaurosis 6 |
| RS398124358 |
JPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 17, Cardiovascular phenotype |
| RS398124359 |
SELENON
|
Health Risk |
Conflicting classifications of pathogenicity |
Eichsfeld type congenital muscular dystrophy, SEPN1-related disorder |
| RS398124360 |
SELENON
|
Health Risk |
Pathogenic |
— |
| RS398124365 |
NLGN4X
|
Health Risk |
Conflicting classifications of pathogenicity |
NLGN4X-related disorder, NLGN4X-related disorder |
| RS398124367 |
NLGN4X
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124369 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS398124372 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS398124373 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124374 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS398124378 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS398124379 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS398124380 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Sotos syndrome |
| RS398124381 |
NSD1
|
Health Risk |
Pathogenic |
Squamous cell carcinoma of the head and neck, Squamous cell carcinoma of the head and neck |
| RS398124382 |
NSD1
|
Health Risk |
Likely pathogenic |
— |
| RS398124383 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS398124385 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124386 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sotos syndrome, Inborn genetic diseases |
| RS398124388 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124391 |
ALG8
|
Health Risk |
Pathogenic |
ALG8 congenital disorder of glycosylation, ALG8 congenital disorder of glycosylation |
| RS398124394 |
FKRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2I, Walker-Warburg congenital muscular dystrophy |
| RS398124395 |
FKRP
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2I, Walker-Warburg congenital muscular dystrophy |
| RS398124396 |
GNPTAB
|
Health Risk |
Pathogenic |
— |
| RS398124397 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS398124398 |
GNPTAB
|
Health Risk |
Pathogenic |
— |
| RS398124400 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS398124401 |
SRD5A3
|
Health Risk |
Pathogenic |
SRD5A3-congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS398124402 |
BBS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS398124403 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS398124404 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS398124405 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS398124406 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS398124407 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS398124408 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS398124414 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RAI1-related disorder |
| RS398124415 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
RAI1-related disorder, Inborn genetic diseases |
| RS398124416 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
RAI1-related disorder, RAI1-related disorder |
| RS398124419 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS398124425 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124428 |
PHF6
|
Health Risk |
Pathogenic |
— |
| RS398124429 |
FOXP1
|
Health Risk |
Pathogenic |
— |
| RS398124431 |
RAX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS398124432 |
BBS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, BBS4-related disorder |
| RS398124433 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1F, Usher syndrome type 1F |
| RS398124434 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS398124435 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS398124437 |
MEN1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS398124438 |
UBE3A
|
Health Risk |
Pathogenic |
— |
| RS398124440 |
UBE3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Angelman syndrome, Angelman syndrome |
| RS398124442 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS398124445 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS398124447 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124448 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS398124449 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
TTN-related disorder, TTN-related disorder |
| RS398124450 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS398124455 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS398124463 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS398124465 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS398124466 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, NIPBL-related disorder |
| RS398124467 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS398124470 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS398124471 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS398124472 |
NIPBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS398124473 |
NIPBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS398124474 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS398124475 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS398124476 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS398124477 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS398124478 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS398124479 |
PKHD1
|
Health Risk |
Pathogenic |
— |
| RS398124480 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 4, Autosomal recessive polycystic kidney disease |
| RS398124481 |
PKHD1
|
Health Risk |
Pathogenic |
— |
| RS398124483 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal dominant polycystic liver disease |
| RS398124484 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS398124485 |
PKHD1
|
Health Risk |
Pathogenic |
— |
| RS398124486 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS398124487 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS398124491 |
PKHD1
|
Health Risk |
Likely pathogenic |
— |
| RS398124492 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS398124495 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, PKHD1-related disorder |
| RS398124496 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS398124497 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, PKHD1-related disorder |
| RS398124498 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS398124500 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS398124501 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS398124502 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS398124503 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS398124506 |
ARX
|
Health Risk |
Pathogenic |
— |
| RS398124507 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked |
| RS398124508 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS398124510 |
ARX
|
Health Risk |
Pathogenic |
X-linked lissencephaly with abnormal genitalia, Developmental and epileptic encephalopathy |